A Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol written confirmation (Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol WC) is an official document issued by a regulatory agency to a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol manufacturer, verifying that the manufacturing facility of a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol APIs or Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol finished pharmaceutical products to another nation, regulatory agencies frequently require a Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol WC (written confirmation) as part of the regulatory process.
click here to find a list of Pramipexole dihydrochloride monohydrate, Mirapex, Mirapexin, Sifrol suppliers with Written Confirmation (WC) on PharmaCompass.